A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. Objective: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scriba, Thomas J., Tameris, Michele, Smit, Erica, van der Merwe, Linda, Hughes, E. Jane, Kadira, Blessing, Mauff, Katya, Moyo, Sizulu, Brittain, Nathaniel, Lawrie, Alison, Mulenga, Humphrey, de Kock, Marwou, Makhethe, Lebohang, Janse van Rensburg, Esme, Gelderbloem, Sebastian, Veldsman, Ashley, Hatherill, Mark, Geldenhuys, Hendrik, Hill, Adrian V. S., Hawkridge, Anthony, Hussey, Gregory D., Hanekom, Willem A., McShane, Helen, Mahomed, Hassan
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326425/
https://ncbi.nlm.nih.gov/pubmed/22281831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1548OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados